ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,235Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 99

$610K Total Retail Price of All Prescriptions

Rank: 19 out of 99

542 Patients Receiving at Least One Drug in Part D
92% Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in North Dakota
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

7% of this provider’s 542 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

6% of this provider’s 542 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in North Dakota
SIMVASTATIN 510 482 135 1 2
LEVOTHYROXINE SODIUM 339 289 78 2 1
AMLODIPINE BESYLATE 310 305* 77 3 6
FUROSEMIDE 303 282 91 4 3
LISINOPRIL 288 283* 71 5 4
METOPROLOL TARTRATE 270 265* 51 6 7
OMEPRAZOLE 240 228 70 7 5
METOPROLOL SUCCINATE 229 216 59 8 8
METFORMIN HCL 225 190 62 9 12
ATORVASTATIN CALCIUM 218 200 63 10 10
POTASSIUM CHLORIDE 213 197 46 11 9
WARFARIN SODIUM 211 200 45 12 14
ATENOLOL 187 182* 42 13 16
SERTRALINE HCL 150 145* 29 14 15
DONEPEZIL HCL 150 150 27 14 25
HYDROCHLOROTHIAZIDE 149 149 38 16 11
CLOPIDOGREL 128 116 28 17 20
PREDNISONE 127 122* 38 18 26
GABAPENTIN 120 79 22 19 17
LANTUS SOLOSTAR 119 114* 28 20 33
HYDROCODONE-ACETAMINOPHEN 117 96 29 S3 21 19
ENALAPRIL MALEATE 112 107* 29 22 51
TRAMADOL HCL 111 111 25 23 18
CITALOPRAM HBR 106 101* 27 24 21
LOSARTAN POTASSIUM 93 93 32 25 13
ISOSORBIDE MONONITRATE ER 89 75 19 26 30
LORAZEPAM 88 72 28 B 27 35
LANTUS 78 73* 17 28 49
CRESTOR 78 73* 18 28 29
CARVEDILOL 78 73* 15 28 27
TRAZODONE HCL 74 69* 15 31 45
ZOLPIDEM TARTRATE 73 61 18 32 37
GLYBURIDE 72 56 15 R 33 116
NOVOLOG FLEXPEN 71 66* 14 34 67
MIRTAZAPINE 66 54 15 35 36
BD ULTRA-FINE PEN NEEDLE 63 58* 22 36 87
PANTOPRAZOLE SODIUM 63 <11 <11 36 38
DIGOX 62 57* 14 38 41
CIPROFLOXACIN HCL 60 55* 45 39 66
FLUOXETINE HCL 58 58 14 40 59
INSULIN SYRINGE* 54 49* 14 41 129
TAMSULOSIN HCL 54 54 16 41 28
AMITRIPTYLINE HCL 53 48* 16 R 43 65
DIOVAN 53 33 11 43 50
AZITHROMYCIN 53 48* 45 43 72
CLONAZEPAM 52 47* 15 B 46 73
GLIMEPIRIDE 52 47* 18 46 43
OXYCONTIN 51 <11 <11 S2 48 167
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 23, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.